Home > Boards > Free Zone > User's Groups > "Savvy Trades and Investments”

QBL 3 month update of MMJ and Hemp

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Alexulf Member Profile
Followed By 4
Posts 377
Boards Moderated 5
Alias Born 03/20/17
160x600 placeholder
Alexulf   Thursday, 03/08/18 04:40:53 PM
Re: None
Post # of 46427 
QBL 3 month update of MMJ and Hemp incl links.

Targeting Premium DSO Bauxite 2018 and start operations this year.

QBL Quarterly report december 2017;

QBL Emerging as a keyplayer in Medical Cannabis;

January 8, 2018
• VitaCann Pty Ltd (“VitaCann” subsidairy) has signed an exclusive joint venture agreement (the “Joint Venture”) for a World First Pharmaceutical Grade Medical Cannabis Extended Release Pill with Canntab Therapeutics Limited (“Canntab”) of Toronto,Canada.,


Breakthrough for GMP Quality Medicinal Cannabis

December 11, 2017

The Board at Queensland Bauxite (ASX:QBL) is excited with the recent success and progress of its investment in Medical Cannabis Ltd (“MCL” or “the Company”), particularly as the medicinal focused arm of that Company, Vitacann, has signed a Letter of Intent for a joint venture subject to full documentation with an Israeli recommended group of North American chemists who have put together what we understand to be a world first in the Medical Cannabis industry. Read More;

MCL (subsidiary to QBL), dec 27, Escalates Hemp Seed Production.

MCL and AEB join to develop Cannabis veterinary medications; The Boards of Queensland Bauxite Limited (ASX:QBL) and Algae.Tec Ltd (ASX:AEB) are delighted to announce a significant Australian ground breaking agreement whereby AEB will exclusively license Medical Cannabis Limited’s Low THC Delta 9 Cannabis cultivars from the uniqu...

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist